ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
QUVIVIQ 50 mg, Filmtabletten - 10
68481003 Idorsia Pharmaceuticals Ltd
QUVIVIQ 50 mg, Filmtabletten01.12.2022
  01.12.2022
(N05CJ03) 
WHO-DDD30.11.2027
10
01.03.10. 
B  
No 
IP 
PR  
k.A.PR
  
7680684810039Synthetika
  
Composition
daridorexantum 50 mg ut daridorexanti hydrochloridum, mannitolum, cellulosum microcristallinum, povidonum K 30, carmellosum natricum conexum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, cellulosum microcristallinum, glycerolum, talcum, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum) pro compresso obducto corresp. natrium 0.655 mg.
Packungsbestandteile
Coated tablets
 
Active AgentDose
Daridorexantum50 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum) pro Compresso Obducto  
(Rubrum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Glycerol  
Hypromellosum Überzug
Magnesii Stearas  
Mannitol  
Povidonum K30  
Silica Colloidalis Anhydrica  
Talcum  
Source
Data was imported : 07.03.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home